Mera Pharmaceuticals, Inc.
MRPI · OTC
10/31/2011 | 7/31/2011 | 4/30/2011 | 1/31/2011 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -26.4% | -0.5% | 35% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 96.5% | 99.7% | 88.3% | 94.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -158.7% | -18.3% | -42% | -52.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -159.9% | -18.1% | -40.2% | -53.7% |
| EPS Diluted | -0 | -0 | -0.01 | -0 |
| % Growth | -595.6% | 99.7% | -9,900% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |